drugset / Trial / NCT01382095
Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of the study is to determine if immunization with a recombinant E. coli protein, dscCfaE, is safe and immunogenic when administered through the skin using a patch.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-08
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LTR192G | Protein / enzyme biologic | 50 ug | Other |
| Subject | dscCfaE | Protein / enzyme biologic | 10 ug | Other |
| Subject | dscCfaE | Protein / enzyme biologic | 50 ug | Other |
| Subject | dscCfaE | Protein / enzyme biologic | 250 ug | Other |